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Background: Celiac disease (CD) is an autoimmune enteropathy induced by dietary wheat gluten
that can have serious consequences if not diagnosed and treated early. It is important to be
familiar with other alterations associated with gluten ingestion due to the multiplicity of clinical
presentations.
Objectives: To describe the most common CD presentation patterns and alterations associated
with gluten in children from the northwest region of Mexico, with an incipient knowledge of its
prevalence.
Patients and methods: Age, sex, family history, and gastrointestinal and extraintestinal symp-
toms were recorded in 24 patients within the time frame of 2006 to 2010. Biochemical and
hematologic data were collected. Anti-gliadin and anti-transglutaminase antibodies were ana-
lyzed in all the cases, and haplotypes (HLA-DQ2/DQ8) and duodenal biopsy were evaluated in
some of the cases.
Results: Of the 24 patients (14 girls and 10 boys), 13 presented with typical CD with symptoms
of poor gastrointestinal absorption; 7 patients with a mean age of 5 years presented with
atypical CD; 2 had disease onset with gastrointestinal and extraintestinal (neurologic) problems;
and 2 with other gluten-related disorders. All of the patients had positive serology; 11/15
presented with HLA-DQ2/DQ8 and 4 with at least one allele; damaged mucosa was observed in
the 6 biopsies taken. A third of the patients were anemic, 6 presented with an albumin value
of < 3.5 g/dL, and 4 with mineral deﬁciencies. A total of 83% of the patients improved with a
gluten-free diet.
 Please cite this article as: Sotelo Cruz N, Calderón de la Barca AM, Hurtado Valenzuela JG. Enfermedad celiaca en nin˜os del noroeste de
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Conclusions: The presentation patterns were: 1) typical CD, 2) atypical CD, 3) CD with gas-
trointestinal and extraintestinal (neurologic) symptoms, and 4) gluten-related disorders other
than CD.







Enfermedad celiaca en nin˜os del noroeste de México: características clínicas
de 24 casos
Resumen
Antecedentes: La enfermedad celiaca (EC) es una enteropatía autoinmune inducida por el
gluten del trigo dietético, con serias consecuencias si no se diagnostica y trata tempranamente.
Hay además otras alteraciones asociadas a la ingestión de gluten, que es importante conocer,
por su multiplicidad de presentaciones clínicas.
Objetivos: Describir los patrones más comunes de presentación de EC y alteraciones asociadas al
gluten en nin˜os de la región noroeste de México, con incipiente conocimiento de su prevalencia.
Pacientes y métodos: Se registraron la edad, el género, la historia familiar y los síntomas gas-
tro y extraintestinales, en 24 pacientes, entre 2006 y 2010. Se recogieron datos bioquímicos
y hematológicos. Se analizaron anticuerpos antigliadinas y antitransglutaminasa en todos los
casos; haplotipos (HLA-DQ2/DQ8) y biopsia duodenal en parte de los mismos.
Resultados: De los 24 pacientes (14 mujeres y 10 varones), 13 presentaron EC típica con sín-
tomas de mala absorción gastrointestinal; 7 promediando 5 an˜os de edad, con EC no típica;
2 iniciaron con problemas gastro y extraintestinales (neurológicos), y 2 con otros desórdenes
asociados al gluten. Todos presentaron serología positiva; 11/15 presentaron HLA-DQ2/DQ8 y 4
al menos un alelo; las 6 biopsias tomadas, mostraron mucosa dan˜ada. Una tercera parte estaban
anémicos, 6 con albúmina < 3.5 g/dL, 4 con deﬁciencias de minerales. El 83% de los pacientes
mejoró con la dieta sin gluten.
Conclusiones: Los patrones de presentación fueron: 1) EC típica; 2) EC no típica; 3) EC con
síntomas gastro y extraintestinales (neurológicos), y 4) sin EC, con otros desórdenes relacionados
con el gluten.
© 2013 Asociación Mexicana de Gastroenterología. Publicado por Masson Doyma México S.A.














































eliac disease (CD) is systemic, it is mediated immunologically,
recipitated by exposure to dietary gluten, and it develops in genet-
cally susceptible individuals. It is characterized by diverse clinical
anifestations, speciﬁc antibodies, haplotypes HLA-DQ2 and DQ8,
nd enteropathy.1,2
CD presents with a wide variety of non-speciﬁc signs and symp-
oms that can be gastrointestinal or extraintestinal and thus has
een classiﬁed as typical, atypical, asymptomatic, subclinical,
nd potential.2--4 Typical pediatric CD is characterized by delayed
rowth, diarrhea, emaciation, loss of appetite, and abdominal
loating; when it appears with any other sign or symptom it is atyp-
cal. Asymptomatic, or silent, CD does not present with clinically
uspicious signs or symptoms, and is subclinical when it is below
he threshold of clinical detection. Potential CD, also called latent
D, is deﬁned by the presence of compatible antibodies and haplo-
ypes, but with no abnormalities in the duodenal mucosa; it may or
ay not present with symptoms or enteropathy.1,2
There is also a recently recognized entity called non-celiac
ensitivity or hypersensitivity to gluten.2,5 It is characterized by
linical symptoms (gastrointestinal) that are very similar to those of
D, the patients present with positive anti-gliadin antibody titers,
ut negative anti-transglutaminase antibody titers.5 They do not
resent with atrophy of the intestinal villi, but they do present
ith eosinophil inﬁltration into the duodenal and colonic mucosa;




pany cases of hypersensitivity, the patients have the HLA-DQ2 and
Q8 haplotypes, and in all cases their symptoms are resolved by a
luten-free diet.
Refractory CD is also well characterized and is deﬁned by its
ymptoms of persistent or recurrent malabsorption and atrophy
f the intestinal villi, despite a strict gluten-free diet during 6-
2 months.2,6 Refractory CD can be type 1 or type 2. In type 1,
he patients do not respond to a gluten-free diet, but their intraep-
thelial lymphocytes are normal. Type 2 is characterized by clones
f abnormal intraepithelial lymphocytes that do not present with
he CD3 and CD8 markers and the T-cell receptor, but they express
D3 intracellularly. It is associated with poor outcome due to the
act that it can progress to T-cell lymphoma.6,7
With this diversity of signs and symptoms, the diagnosis of
D and other gluten-associated alterations tends to be compli-
ated, obscuring the dimension of the problem. It is estimated that
etween 1:100 and 1:200 individuals of any given population suf-
er from some form of CD; however, there are differences among
he published data. For example, for the Mexican population, there
as a 1:37 prevalence of the IgA anti-transglutaminase antibody
esulting from the analysis of serum from healthy donors;8 when
he serum was reanalyzed for anti-endomysial antibodies, preva-
ence decreased to 1:1689. In contrast, in a recent study conducted
n 7,798 persons in the United States, 1:141 were positive for celiac
isease, whereas among 1,686 Mexican Americans in the same study























































bCeliac disease in children from the northwest of Mexico: Cli
The consequences of CD on health, if it is not diagnosed
and treated early on, can be very severe, especially in children,
because it affects their growth and development. The diagnosis
and treatment of CD is recent in Mexico. Therefore, the aim of
this study was to describe the most common presentation patterns
of CD and other gluten-associated alterations in children from the
northwest region of Mexico, with an incipient knowledge of its
prevalence.
Patients and methods
Children and adolescents participated in the study after
their parents gave their informed consent. Within the time
frame of 2006 and 2010, 47 patients with clinical suspicion of
CD were sequentially included in the study. Twenty-three
of them were excluded because they had negative serologic
markers and/or haplotypes or because they presented with
some other pathology. Thus, a total of 24 patients were
selected for the study. The variables taken into account
were: age, sex, family history, and the existence of diseases
such as type 1 diabetes mellitus, thyroiditis, osteoporo-
sis, Down’s syndrome, peripheral neuropathy, ataxia, and
behavioral disorders. The symptoms regarded as typical in
accordance with the Oslo deﬁnitions were chronic diar-
rhea, abdominal bloating, weight loss or growth delay,
loss of appetite, and emaciation.2 Symptoms were con-
sidered atypical when they were isolated gastrointestinal
ones, such as gastroesophageal reﬂux, or if the patient did
not present with malabsorption, such as constipation and
abdominal pain;2 extraintestinal symptoms, such as ane-
mia, neuropathy, fatigue, and low bone density were also
included.1,2
The laboratory work-up was full blood count, serum iron,
creatinine urea, glucose, calcium, albumin, the stool ova
and parasite test, and in some cases the D-xylose absorp-
tion test in blood or urine. The speciﬁc serologic tests
of IgG and IgA anti-gliadin antibodies were done, as well
as IgA anti-transglutaminase through the enzyme linked
immunosorbent assay (ELISA), as previously performed.11
The cut-off point was the mean + 2 SD of the optic den-
sity of 30 serum samples from healthy children. Reactivity
was expressed as an index; in other words, the optic den-
sity of the serum to be tested divided by the value of the
cut-off point. The indices equal to or greater than 1.0 were
regarded as positive.12 Low titers were between 1 and 5,
moderate between 5 and 10, high between 10 and 20, and
very high was greater than 20. In 15 children DNA extracted
from the total blood was analyzed along with the HLA-DQ2
and HLA-DQ8 haplotypes by conventional PCR, using the
indicators designed by Olerup et al.13 In 6 cases, intestinal
mucosa biopsy was taken with a peroral capsule or through
endoscopy, and analyzed.
Dietary follow-up was carried out with the aid of a dietary
guide for children with celiac disease that were between
the ages of one and 6.14 Likewise, the speciﬁc antibodies
continued to be monitored during follow-up until they were
negative.
The study project was approved by the ethics committees
of the Hospital Infantil de Estado de Sonora and the Centro
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The study was a description of cases and the index val-
es used for the ELISA tests were the average of at least
dilutions that were duplicated (8 absorbance readings).
esults
f the 24 patients, 14 were girls and 10 were boys. All except one,
ho at the beginning of the study was already on a gluten-free
iet, were positive for IgA and IgG anti-gliadin antibodies. That
ame case and two that were under 2 years of age, were negative
or IgA anti-transglutaminase; the rest of the children presented
ith positive indices. Four of the patients presented with very
igh speciﬁc antibody indices, 5 with high indices, 2 with moderate
ndices, and the remaining 13 with low indices. Of the 15 children in
hom genetic predisposition was analyzed, 7 had HLA-DQ2, 4 had
LA-DQ8, and the remaining 4 had at least one allele of the two hap-
otypes. There were signs of malnutrition affecting development
n 3 of the children that presented with underweight above 40%;
had underweight between 26 and 39%, and one child presented
ith underweight of 22%. In regard to minerals, 6 presented with
ess than 40 u/dL of serum iron and hemoglobin was under 10 g/dL
n 8 children; four presented with hypocalcemia.
Taking into account the signs and symptoms, the speciﬁc anti-
ody indices, and in some cases, the haplotypes or biopsy, the most
ommon presentation patterns in the sample were classiﬁed into
groups: 1) CD with a typical presentation, 2) CD with an atypi-
al onset, 3) CD with gastrointestinal and extraintestinal symptoms
malabsorption and neurologic problems), and 4) non-celiac gluten-
elated disorders.
Table 1 presents 13 cases, 10 of which were children between
months and 3 years of age that had characteristics of typical
D development. In other words, they were small and presented
ith the sudden and severe gastrointestinal symptoms of malab-
orption, malnutrition, and associated complications, shortly after
luten introduction.15,16 The 3 remaining cases were in this cate-
ory due to their malabsorption problems2, even though gluten was
ot introduced into their diet until later in their lives.
Among the most common signs and symptoms in the patients
ith typical CD in Table 1 were chronic diarrhea in 11/13 and abdom-
nal bloating (5/13). This group presented with the highest antibody
ndices of more than 10 or 20 times the healthy reference value.
In relation to the follow-up of the gluten-free diet and its effects
n nutritional status, all the children in the group presented in
able 1 responded adequately. Those that presented with some
egree of malnutrition upon CD diagnosis, recovered the weight and
eight for their age with dietary treatment. Only in case 5, did the
utritional status recovery take several months after treatment.
Table 2 shows 7 cases of children from 15 months to 9 years of
ge, with a mean age of 6 years. They presented with isolated gas-
rointestinal symptoms at the onset of CD, as well as extraintestinal
omponents as deﬁned by Aurangzeb et al.15 Among their signs and
ymptoms were gastroesophageal reﬂux in 4/7 and abdominal pain
n all 7. Those that presented with malnutrition also had a history
f recurrent respiratory disease. None of these cases had high or
ery high antibody indices.
In some of the patients in Table 2, there was no short-term dis-
ppearance of the symptoms once the gluten-free diet was begun;
nstead, it was gradual. The same held true for their nutritional sta-
us recovery, which was achieved several months after the dietary
reatment. Case 15 did not recover the rate of growth until more
han one year after treatment. Symptoms were reduced in case 18,
ut reﬂux did not completely disappear.
Table 3 shows 2 cases of children 4 and 16 years of age that could
e classiﬁed as having atypical CD onset, but they were placed in a
eparate table because they both began the study with neurologic
roblems. One of the patients had behavioral and attention deﬁcit
isorders; the other presented with cerebral palsy. In both cases,
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Table 1 Characteristics of cases with typical celiac disease.








1 3 y. F Diarrhea, abdominal distension 14.01 1.73 10.16 NA
2 9 m. M Chronic diarrhea, malabsorption,
grade 3 malnutrition
37.68 5.64 36.70 Marsh biopsy-2
3 3 y. M Diarrhea, weight loss, recurrent
abdominal pain
10.01 3.10 12.29 NA
4 11 m. F Diarrhea, abdominal distension 14.76 3.60 11.33 NA
5 2 y. F Intermittent chronic diarrhea,
grade 2 malnutrition
8.80 3.50 3.80 NA
6 2 y. M Diarrhea, abdominal distension,
retarded growth, grade 2
malnutrition
21.40 4.10 13.13 HLA-DQ2
Marsh biopsy-3
7 2.9 y. M Diarrhea and dehydration, grade 2
malnutrition, anemia, tetany,
muscular hypotrophy,
malnutrition, underheight for age
35.70 3.50 26.80 HLA-DQ8
Marsh biopsy-3
8 6 m. M Hypocalcemia, abdominal
distension
1.32 1.37 1.10 DQA1*0301
9 11 m. F Intermittent diarrhea for 3 months 2.13 8.80 3.80 NA
10 8 y. F Diarrhea, malabsorption, grade 1
malnutrition
20.00 23.30 11.00 HLA-DQ2
DQA1*0301
11 8 y. F Abdominal pain, chronic diarrhea 23.30 1.00 9.70 NA
12 11 m. M Diarrhea, grade 3 malnutrition,
abdominal distension, emaciation,
malabsorption syndrome
2.79 1.85 1.26 HLA-DQ2
13 5 y. F Vomiting, diarrhea, grade 2
malnutrition














































aNA: not analyzed; TG: transglutaminase.
a Index: optic density of the serum to be tested divided by the v
he neurologic problems (extra-intestinal) presented together with
he gastrointestinal symptoms - constipation in one of them and
iarrhea in the other; and they both had advanced malnutrition.
ne of the cases had low titers, but positive speciﬁc antibodies,
hereas they were between moderate and high in the other. There
as extra evidence in both cases; a biopsy of the intestinal mucosa
n one case and HLA-DQ8 detection in the other.
The cases shown in Table 3 were difﬁcult to follow in regard to
ymptom disappearance and nutritional status recovery. In fact, the
oungest boy had partial recovery and the older boy had only par-
ial symptom disappearance, but he did not have nutritional status
ecovery; they could be considered cases of refractory CD.
Table 4 presents 2 cases of gluten-related disorders; one,
ediated by IgE, with an allergic response, and the other, medi-
ted by IgA, with non-celiac gluten sensitivity, given that its IgA
nti-transglutaminase antibody index was negative. The signs and
ymptoms in the two patients, one 3 years and 5 months old and the
ther 13 years old, were gastrointestinal and remitted with a gluten-
ree diet. After a gluten challenge, allergy mediated by IgE was
emonstrated in the youngest girl; in the other girl non-celiac gluten
ensitivity was suspected and she continued a gluten-free diet.
iscussionor many years CD was a rare pathology in many countries, and
exico was no exception. Nevertheless, in the last 15-20 years, its




tof the cut-off point.
ommon inﬂammatory disease of the small bowel.16 It is an autoim-
une disease that not only presents with exposure to gluten, but
ather with a combination of other factors, including genetic pre-
isposition and abnormalities in the structure of the small bowel.17
he procedures for the study and diagnosis of patients suspected of
aving CD have improved measurably.18,19
CD diagnostic criteria have changed as knowledge of its patho-
enesis has increased and the techniques for its study have
mproved. Before its pathogenic mechanism was known, only its
linical symptoms were managed; tests were not very speciﬁc and
he only way to conﬁrm intestinal damage was through biopsy
f the mucosa. In 1969 the European Society of Paediatric Gas-
roenterology, Hepatology and Nutrition (ESPGHAN) established the
rst diagnostic criterion. It consisted of taking three biopsies: one
pon diagnosis, another after a gluten-free diet, and the third after
gluten challenge. In 1990 this criterion was changed to a single
iopsy, together with serologic analysis and the clinical response to
he gluten-free diet.20
Positive biopsy has been the criterion standard for CD diagno-
is. However, over the last few years there has been a tendency
o use the serologic analysis for making the deﬁnitive diagno-
is. The importance and usefulness of this type of analysis is
ased not only on the knowledge of the presence of antibodies
gainst the endogenous antigen, but also on a very important step
n the pathogenic mechanism. In 1998, in two independent stud-
es, Molberg et al.21 and van de Wal et al.22 showed that the
issue transglutaminase modiﬁed the gliadin peptides, increasing
heir reactivity for T-cells in CD. Thus, patients with CD not only
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Table 2 Characteristics of cases with atypical celiac disease onset.








14 1y. 3m. F Onset at 7 months with
constipation, with episodes of
abdominal pain and diarrhea
added at one year at one year
1.03 1.05 0.57 HLA-DQ2
15 2 y. F Gastroesophageal reﬂux
at 5 months of age, pain and
abdominal distension, anemia
and retarded growth at 9 months,
grade 2 malnutrition, gluten-free
















16 9 y. F Abdominal pain, bloating,
hyporexia
0.68 1.00 1.00 DQB1*0201
17 1 y. 11m. F Gastroesophageal reﬂux,
recurrent abdominal pain,
abdominal distension, recurrent
respiratory infections, grade 2
malnutrition
2.76 2.05 0.78 HLA-DQ2
Marsh biopsy-3
18 9 y. M Chronic gastroesophageal reﬂux,
abdominal pain
1.66 1.75 2.11 HLA-
DQ8DQA1*0501
19 7 y. M Abdominal pain and chronic
gastroesophageal reﬂux,
afterwards intermittent diarrhea
3.49 2.43 2.10 HLA-DQ8
DQA1*0501
20 2 y. F Bloating, abdominal pain 4.80 2.67 2.90 DQA1*0301
alue
iTG: transglutaminase.
a Index: optic density of the serum to be tested divided by the v
present with antibodies against the gliadins, but also against their
own transglutaminase.
Therefore, diagnosis focuses on the detection of IgA anti-gliadin,
anti-endomysial, and anti-transglutaminase antibodies. The latter





Table 3 Characteristics of cases of celiac disease with gastro and
Case Age/sex Signs and symptoms
IgA
ant
21 4 y. M Infantile cerebral palsy, secondary













a Index: optic density of the serum to be tested divided by the valueof the cut-off point.
n different populations.17 Due to the fact that 2% of the patients
ith CD are IgA-deﬁcient, IgG is also quantiﬁed. Analyses of the
nti-deamidated gliadin peptide antibodies are the most recent;
hat is, just as they would be found after proteolytic digestion and









1 1.29 1.08 Marsh biopsy-3
0 2.80 8.60 HLA-DQ8
DQB1*0201
of the cut-off point.
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Table 4 Characteristics of cases with other gluten-associated alterations.








23 3y. 5m. F Vomiting, diarrhea, colic, hyporexia.
After a gluten-free diet, a challenge
produced a reaction. IgE antibodies
against wheat proteins were detected
1.42 1.27 0.82 DQB1*0201
DQB1*0302
24 13 y. F Recurrent abdominal pain.
Alternating diarrhea and
constipation. Pain after ingesting
products made with wheat


















































































Ca Index: optic density of the serum to be tested divided by the v
re reagent kits that simultaneously quantify IgA and IgG against
hose peptides.3,23
In very young children, as was the case with many of the patients
n the present study, there is better sensitivity of IgA antibodies
gainst gliadins than against transglutaminase or endomysium.24
herefore, anti-gliadin antibody analysis is regarded as necessary
n children < 24 months old, with signs and symptoms suggestive of
D.23 Cases 14 and 17 in Table 2 show this very clearly; their indices
f anti-gliadin antibodies were positive, whereas their indices
gainst transglutaminase were negative. In fact, cases 15 and 17
howed clearly affected biopsies (Marsh 2 and 3), even though their
nti-transglutaminase antibody indices were negative. When the
linical results, serologic analysis, and biopsy results are conﬂicting,
LA-DQ2 and DQ8 analysis can be helpful. If these haplotypes are
ot found, it is certain that there is no CD since almost all patients
resent with one or both haplotypes.1,16,25
According to the ESPAGHAN1, DQ2 and DQ8 haplotype analysis
hould ﬁrst be carried out for diagnosing asymptomatic children
uspected of having CD. Their absence indicates there is no need
o continue ordering more studies to rule out CD. This procedure
as followed for the cases in Table 2. Case 15 was a girl that from
he age of 7 months presented with intestinal symptoms but no
iarrhea. Anti-gliadin antibodies were not analyzed and her anti-
G antibodies were negative. A biopsy revealed moderate atrophy.
n addition, she presented with HLA-DQ2; the gluten-free diet and a
luten challenge contributed to the CD diagnosis. On the other hand,
ases 17, 18, and 19 presented with conspicuous gastroesophageal
eﬂux, which is not among the most mentioned in the bibliography.
he 3 patients presented with predisposing haplotypes. In an anal-
sis of Canadian children with CD, 8% of them presented with reﬂux
t the beginning of the study.26
Of the 15 cases analyzed for haplotypes, the majority presented
ith the DQA1*0501 and DQB1*0201 alleles or the HLA-DQ2.5 hap-
otype, that make up both alleles. Only 3 of the cases could be
LA-DQ2.2 (DQA1*0201 and DQB1*0202) and 4 were HLA-DQ8; this,
espite the fact that in a population of newborn infants from
onora, the proportion of DQ2 was almost equal to that of DQ8
1.2:1). 27 According to different authors, DQ2.5 has a greater pre-
isposition to CD than DQ2.2,28 given that it is found on the surface
f the antigen-presenting cells, and so has a greater possibility to
nteract.4,25 HLA-DQ2 is also thought to have greater predisposi-
ion than HLA-DQ8, because its expressed molecule binds to a much
ider range of peptides.29
The HLA-DQ2 and DQ8 haplotypes in the study population
ould also be important in deciding the type of serologic analysis
o be carried out. Unlike HLA-DQ8 that can recognize native or
I
t
yof the cut-off point.
eamidated gliadin peptides, the T-cells that are restricted to
LA-DQ2 have a marked preference for the deamidated ones.4
herefore, the circulating antibodies could differ and perhaps it
ould not be necessary to analyze the deamidated gliadin peptide
ntibodies in a population with a preponderance of HLA-DQ8,
uch as those of the American Indians;30 nor would it be the most
ppropriate in very young children, since their immune response is
irected against non-deamidated gliadins.31
Due to their confusing symptoms, several of the study patients
ere not diagnosed with CD at the onset of the disease. This hap-
ens everywhere in the world, even in the developed countries that
ave recognized CD for many years. In adults, diagnosis is commonly
elayed for 11 to 13 years, but it is also delayed in children.26,32
he clearest case in the present study was case 22, an adolescent
hose mother explained that his gastrointestinal symptoms began
hen he was very young, but that his neurologic symptoms were
ore remarkable. For this reason the CD diagnosis was not made
ntil he was 16 years old.
Of the 24 cases presented herein, biopsies of the intestinal
ucosa were only taken in 6 of them. According to the ESPGHAN,
f there is a strong clinical suspicion of CD and positive speciﬁc
ntibodies, HLA-DQ2 and DQ8 analysis can aid in ruling out CD
iagnosis.1 Thus, in addition to the 6 patients with positive biopsy,
nly 2 more could be considered diagnosed. Nevertheless, 7 cases
ere of children under the age of 2 years, whose speciﬁc antibody
iters might not be very high, as mentioned before. In 3 other cases,
he titers were high but the haplotypes could not be analyzed at the
ime they were being seen. In the rest of the cases, biopsies were
ot taken because the parents would not allow it. However, espe-
ially in the children with typical CD, the symptoms unequivocally
emitted with the gluten-free diet and the antibody indices became
egative.
On the other hand, in addition to their genetic predisposition,
he lactation and complementary feeding regimens were inade-
uate for the majority of the study patients. In this population
nly 29% of the children were breast-fed until 3 months of age, and
ereals were introduced into their diet very early.33--35 According to
varsson et al.,36 this is a factor that promotes the development of
D in genetically predisposed children.
onclusionsn conclusion, the cases were grouped together by similarities in
he symptomatology. Typical CD was the most common type in the
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was found in children of different ages; CD with gastrointestinal and
extraintestinal (such as neurologic) symptoms; and gluten-related
disorders with no CD. This manner of classiﬁcation was used to
describe the patterns presented by the cases in the study popu-
lation.
CD should be evaluated in the context of clinical signs, serologic
markers, haplotypes, and intestinal biopsy histology, along with the
response to a gluten-free diet, and in different geographic regions,
in order to have a complete description at the national level. The
criteria of the ESPGHAN should be followed for making the deﬁnitive
diagnosis of CD.
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